Information Links
Mims
Main Navigation
Drugs
Conditions
Travel
ArticlesNew drugs
New biologic for severe eosinophilic asthma
Benralizumab (Fasenra) is the latest biologic to be...
First glatiramer generic available to prescribe for MS
Brabio (glatiramer acetate) is a generic version of...
First treatment for primary progressive MS launched
Ocrevus (ocrelizumab) is the first disease-modifying...
New low-dose levonorgestrel IUS provides five years' contraceptive cover
Kyleena is a new smaller-framed intrauterine system...
New analgesic combines an opiate with an NSAID
Skudexa is an oral analgesic containing a combination...
New once-daily triple combination inhaler for COPD
Trelegy Ellipta is the second 3-in-1 treatment for...
Dupilumab: first biologic for moderate-to-severe atopic dermatitis
Dupilumab (Dupixent) is the first biologic treatment...
Guselkumab further extends choice in psoriasis prescribing
Tremfya (guselkumab) is licensed for the treatment...
Fingerprick-free glucose monitoring system available on the NHS
A glucose monitoring system that does not require regular...
Combined LABA/steroid inhaler added to Easyhaler range
Fobumix Easyhaler 320/9 (budesonide/formoterol) is...
MIMS Product Slides
Product overviews prepared by the MIMS team, in a handy slide format.
Slides are initiated, funded & reviewed by the companies specified.
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
